Antibody therapy for Ebola: is the tide turning around?
X Qiu, GP Kobinger - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
Ebola viruses can cause severe hemorrhagic fever in humans and nonhuman primates with
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
[PDF][PDF] Antibody therapy for Ebola
X Qiu, GP Kobinger - Human Vaccines & Immunotherapeutics, 2014 - researchgate.net
2 Human Vaccines & Immunotherapeutics Volume 10 Issue 4 components that could be
reactogenic in humans. This has led to mAbs having marked successes in the clinic9, 10 …
reactogenic in humans. This has led to mAbs having marked successes in the clinic9, 10 …
Antibody therapy for Ebola: is the tide turning around?
X Qiu, GP Kobinger - Human vaccines & …, 2014 - pubmed.ncbi.nlm.nih.gov
Ebola viruses can cause severe hemorrhagic fever in humans and nonhuman primates with
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
Antibody therapy for Ebola: is the tide turning around?
X Qiu, GP Kobinger - Human Vaccines & Immunotherapeutics, 2014 - europepmc.org
Ebola viruses can cause severe hemorrhagic fever in humans and nonhuman primates with
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
Antibody therapy for Ebola: Is the tide turning around?
X Qiu, GP Kobinger - Human Vaccines and …, 2014 - researchexperts.utmb.edu
Ebola viruses can cause severe hemorrhagic fever in humans and nonhuman primates with
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
[HTML][HTML] Antibody therapy for Ebola: Is the tide turning around?
X Qiu, GP Kobinger - Human Vaccines & Immunotherapeutics, 2014 - ncbi.nlm.nih.gov
Ebola viruses can cause severe hemorrhagic fever in humans and nonhuman primates with
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
fatality rates up to 90%, and are identified as biosafety level 4 pathogens and CDC Category …
[引用][C] Antibody therapy for Ebola
X Qiu, GP Kobinger - Human Vaccines & Immunotherapeutics, 2014 - cir.nii.ac.jp
Antibody therapy for Ebola | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …